New hip liner under Long-Term watch: will it hold up?

NCT ID NCT05587244

ENROLLING_BY_INVITATION Disease control Sponsor: Zimmer Biomet Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study is following 202 people who received a special hip liner during hip replacement surgery. The goal is to see how long the liner lasts and whether it causes any problems over time. Participants are adults aged 18 to 80 with conditions like arthritis or hip fractures. The study will track device survival and any side effects for up to 10 years.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: G7 Freedom Constrained Vivacit-E Acetabular Liners (a medical device used in hip replacement surgery)
What this could lead to: If successful, this study could confirm that this hip liner is safe and works well over the long term, helping people with hip problems get a reliable replacement option.
What could go wrong: This is an observational follow-up study, not a randomized trial, so results may not apply to everyone. The device could still fail or cause complications like dislocation or infection over time.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for AVASCULAR NECROSIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

avascular necrosis bone fracture femoral neck fracture Fractures, Ununited Hip Dislocation hip fracture osteoarthritis osteoarthritis, hip osteonecrosis rheumatoid arthritis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

AVASCULAR NECROSIS DISLOCATION, HIP FEMORAL NECK FRACTURES NON-UNION FRACTURE OSTEOARTHRITIS, HIP RHEUMATOID ARTHRITIS TROCHANTERIC FRACTURES

Contacts and locations

Locations

Jersey City Medical Center, Inc

Livingston, New Jersey, 07039, United States
Medical City Plano

Plano, Texas, 75075, United States
TOA Research Foundation

Knoxville, Tennessee, 37923, United States
The Ohio State University

Columbus, Ohio, 43201, United States
The University of Texas Health Science Center of Houston

Houston, Texas, 77030, United States
University of Alabama at Birmingham

Birmingham, Alabama, 35205, United States
University of Florida Board of Trustees

Gainesville, Florida, 32611, United States
University of Southern California

Los Angeles, California, 90033, United States
University of Utah

Salt Lake City, Utah, 84108, United States
West Virginia University

Morgantown, West Virginia, 26506, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.